Published in Int J Biol Sci on January 01, 2017
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2002) 12.09
Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 11.80
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol (2003) 10.21
Management of sepsis. N Engl J Med (2006) 9.01
Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10
IRAK-M is a negative regulator of Toll-like receptor signaling. Cell (2002) 6.79
Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 6.38
Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev (2009) 5.64
Sepsis definitions: time for change. Lancet (2013) 5.63
Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest (2007) 5.55
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol (2007) 5.48
Dendritic cells in a mature age. Nat Rev Immunol (2006) 5.03
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol (2005) 4.91
The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol (2009) 4.53
Pathophysiologic response to severe burn injury. Ann Surg (2008) 3.73
Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med (2007) 3.63
AGA Institute technical review on acute pancreatitis. Gastroenterology (2007) 3.18
Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol Cell (2003) 3.03
Interstitial leukocyte migration and immune function. Nat Immunol (2008) 2.99
Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest (2008) 2.90
Regulatory T cells under scrutiny. Nat Rev Immunol (2003) 2.64
The pathogenesis of sepsis. Annu Rev Pathol (2011) 2.55
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47
The structural basis of function in Cys-loop receptors. Q Rev Biophys (2010) 2.45
Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med (2007) 2.41
Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 2.28
Cholinergic control of inflammation. J Intern Med (2009) 2.12
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med (2005) 1.96
Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood (2013) 1.79
Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv (2010) 1.78
Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol (2004) 1.72
Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol (2012) 1.67
Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol (2006) 1.64
Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock (2009) 1.63
Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol (2007) 1.60
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology (2013) 1.55
Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int (2008) 1.55
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol (2009) 1.53
Protective effect of nicotine on lipopolysaccharide-induced acute lung injury in mice. Respiration (2010) 1.46
Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol (2014) 1.44
Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. Crit Care Med (2011) 1.43
The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res (2008) 1.43
Neutrophil paralysis in sepsis. Shock (2010) 1.40
Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev (2004) 1.38
Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. J Neurosci (2000) 1.37
A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology (2012) 1.33
Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine. J Pharmacol Exp Ther (2009) 1.33
Pathogenic mechanisms of acute pancreatitis. Curr Opin Gastroenterol (2012) 1.29
Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans (2006) 1.28
Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One (2007) 1.27
Plasticity of human CD4 T cell subsets. Front Immunol (2014) 1.25
Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol (2012) 1.24
The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem Soc Trans (2003) 1.22
Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol (2009) 1.21
Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease. Curr Top Med Chem (2010) 1.21
Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci (2010) 1.20
Intracellular trypsin induces pancreatic acinar cell death but not NF-kappaB activation. J Biol Chem (2009) 1.19
New insights into the pathogenesis of pancreatitis. Curr Opin Gastroenterol (2013) 1.18
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care (2009) 1.16
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol (2009) 1.14
Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2013) 1.13
Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism. Shock (2007) 1.12
Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor α7 subunit gene knockout mice. Ann Rheum Dis (2010) 1.09
Selective alpha7 nicotinic acetylcholine receptor ligands. Curr Med Chem (2006) 1.09
Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol (2013) 1.07
Neuroimmune regulation of ventilator-induced lung injury. Am J Respir Crit Care Med (2010) 1.05
CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive. Immunology (2007) 1.04
Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. J Pharmacol Exp Ther (2010) 1.04
Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol (2012) 1.03
Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis. J Immunol (2011) 1.02
Electroacupuncture pretreatment attenuates cerebral ischemic injury through α7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats. J Neuroinflammation (2012) 1.01
Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview. Pharm Res (2010) 1.00
Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans. Shock (2011) 1.00
Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages. Shock (2009) 1.00
α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol Med (2014) 0.97
Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia. Free Radic Biol Med (2007) 0.96
Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochem Int (2009) 0.96
Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction. Antioxid Redox Signal (2011) 0.96
Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration. Neurosci Biobehav Rev (2007) 0.95
Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors. Acta Pharmacol Sin (2012) 0.95
α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum. Adv Exp Med Biol (2012) 0.94
Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Crit Care Med (2002) 0.94
Targeting α-7 nicotinic acetylcholine receptor in the enteric nervous system: a cholinergic agonist prevents gut barrier failure after severe burn injury. Am J Pathol (2012) 0.93
Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury. Am J Physiol Renal Physiol (2008) 0.93
Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria. PLoS One (2012) 0.92
Nicotine reduces TNF-α expression through a α7 nAChR/MyD88/NF-ĸB pathway in HBE16 airway epithelial cells. Cell Physiol Biochem (2011) 0.90
Stimulation of the α7 nicotinic acetylcholine receptor protects against sepsis by inhibiting Toll-like receptor via phosphoinositide 3-kinase activation. J Infect Dis (2013) 0.90
Toll-like receptors 2 and 4 contribute to sepsis-induced depletion of spleen dendritic cells. Infect Immun (2009) 0.90
Lipopolysaccharide upregulates α7 acetylcholine receptors: stimulation with GTS-21 mitigates growth arrest of macrophages and improves survival in burned mice. Shock (2012) 0.89
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury. Br J Anaesth (2011) 0.88
The influence of nicotine on granulocytic differentiation - inhibition of the oxidative burst and bacterial killing and increased matrix metalloproteinase-9 release. BMC Cell Biol (2008) 0.88
Inhibition of Toll-like receptor 2-mediated interleukin-8 production in Cystic Fibrosis airway epithelial cells via the alpha7-nicotinic acetylcholine receptor. Mediators Inflamm (2010) 0.88
Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice. Mol Med (2015) 0.88
Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction. Neuroscience (2003) 0.87
2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands. Prog Med Chem (2004) 0.87
Non-neuronal cholinergic system in regulation of immune function with a focus on α7 nAChRs. Int Immunopharmacol (2015) 0.87